| __timestamp | Axsome Therapeutics, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1392830 | 22570000 |
| Thursday, January 1, 2015 | 2419289 | 24378000 |
| Friday, January 1, 2016 | 6343648 | 26621000 |
| Sunday, January 1, 2017 | 7206691 | 28653000 |
| Monday, January 1, 2018 | 9351522 | 37734000 |
| Tuesday, January 1, 2019 | 13598030 | 41884000 |
| Wednesday, January 1, 2020 | 28896749 | 64435000 |
| Friday, January 1, 2021 | 66646205 | 57483000 |
| Saturday, January 1, 2022 | 159253661 | 70062000 |
| Sunday, January 1, 2023 | 323123000 | 52790000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Axsome Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Over this period, Axsome's SG&A expenses skyrocketed by over 23,000%, reflecting its aggressive growth strategy. In contrast, Ligand's expenses grew by a more modest 134%, indicating a steadier approach.
This comparison underscores the diverse strategies within the biotech sector, where companies balance growth with operational costs.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Axsome Therapeutics, Inc.
Comparing SG&A Expenses: GSK plc vs Ligand Pharmaceuticals Incorporated Trends and Insights
Selling, General, and Administrative Costs: Neurocrine Biosciences, Inc. vs Ligand Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Axsome Therapeutics, Inc.
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated Trends and Insights
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Axsome Therapeutics, Inc. and Novavax, Inc.
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Mesoblast Limited
Breaking Down SG&A Expenses: Ligand Pharmaceuticals Incorporated vs Novavax, Inc.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Xencor, Inc.